vancomycin has been researched along with bmap-28 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cirioni, O; Ghiselli, R; Giacometti, A; Minardi, D; Mocchegiani, F; Muzzonigro, G; Orlando, F; Riva, A; Saba, V; Scalise, G; Silvestri, C; Skerlavaj, B; Tomasinsig, L; Zanetti, M | 1 |
1 other study(ies) available for vancomycin and bmap-28
Article | Year |
---|---|
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection.
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Biofilms; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Proteins; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Stents; Ureter; Vancomycin | 2008 |